Cardarine (GW-501516) is a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It was originally researched for its potential to influence metabolism, endurance, and lipid profiles.
While early studies suggested possible benefits in metabolic function and energy utilization, further research raised significant safety concerns. As a result, development for human therapeutic use was discontinued. Cardarine is not an approved medication and is generally classified as a research compound.
Reported Effects
- Increased endurance capacity (observed in preclinical studies)
- Enhanced fatty acid oxidation
- Potential impact on cholesterol and lipid metabolism
- Activation of PPARδ pathways
Reviews
There are no reviews yet.